Pharmacy & Biological Sciences
Category
FDA Forms Drug Shortages Task Force
The task force is charged with identifying the reasons why some shortages remain a persistent challenge and to look for holistic solutions to addressing the underlying causes for these shortages.
Fund Cancer Detection, Not a “Cure”
Your best weapon to defeat the beast known as cancer is early detection. So, why is funding so focused on finding a “cure,” instead of screening?
Are Doctors Bribed by Pharma? An Analysis of Data.
An in-depth look at a recent paper that explores correlational data relating opioid prescribing to opioid manufacturer payments.
Retooled Vaccine Raises Hopes As A Lower-Cost Treatment For Type 1 Diabetes
The increasing cost of Type 1 diabetes, one of the most common serious chronic diseases, has created heavy financial burdens for families, with insulin prices more than doubling in the past decade.
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
Take a look at highlights from 15 years of changes in biopharmaceutical manufacturing.
Philanthropists Are Getting Behind a New Push for Government Science Funding
Only one in four Americans believes the U.S. government’s role in funding research is irreplaceable, according to a study by ScienceCounts.
FDA Involves Patient Perspectives in Regulatory Review Process
The FDA established the Patient Engagement Advisory Committee in a move to broaden patient engagement and strengthen patients’ voice in regulatory activities.
Do Pharma’s Claims On Drug Prices Pass The Smell Test? We Found 5 Stinkers.
The pharmaceutical industry fears major legislation that would curb prices and shrink profits, and has launched campaigns against it—but how honest are their claims?
Feds Pay $8M+ to Promote ‘Diversity’ in STEM
The National Science Foundation recently issued 27 new grants totaling more than $8 million to promote “diversity and inclusion” in STEM fields.
BU Wins $20M for NSF Engineering Research Center
The recipient’s ultimate goal is to advance nano-bio-manufacturing methods that could lead to large-scale fabrication of functional heart tissue, which could replace diseased or damaged muscle after a heart attack.